Grade My Investments
Home › Free Stock Grades › SIBN

SI-BONE, Inc. (SIBN) Stock Grade

SIBN · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$832.0M
P/E Ratio
—
Revenue Growth (YoY)
+20.2%
Net Margin
-9.4%
Return on Equity
—
Dividend Yield
None

About SI-BONE, Inc.'s fundamentals

SI-BONE, Inc. is a medical device company with a market capitalization of $832.0 million that is experiencing strong revenue growth of 20.2% year-over-year, indicating expanding market adoption of its products. However, the company is not yet profitable, operating at a net margin of -9.4% and reporting a net loss in its latest annual statement, which is common for growth-stage medical device firms investing heavily in product development and commercialization. The company does not pay a dividend, typical for loss-making businesses that retain capital for operations and growth initiatives.

Track SIBN free — no credit card required. Live grade + monthly AI report →